Used in research settings to quantify levels of Clara cell protein (CC16) in biological samples such as serum, plasma, bronchoalveolar lavage fluid, and urine. This assay is particularly valuable in studies related to lung injury and inflammation, as CC16 serves as a biomarker of airway epithelial integrity. It is widely applied in respiratory research, including investigations into asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and environmental or occupational lung damage. The kit enables sensitive and specific detection of CC16, supporting both clinical research and experimental models of pulmonary disease. Results help assess the extent of lung epithelial damage and monitor response to therapeutic interventions.